229 filings
15F-12B
CLYYF
Celyad Oncology SA
9 Feb 24
Securities registration termination (foreign)
6:07am
6-K
CLYYF
Celyad Oncology SA
17 Jan 24
Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
6:33am
6-K
CLYYF
Celyad Oncology SA
21 Dec 23
Publication of a transparency notification received from Fortress Investment Group LLC
6:19am
6-K
CLYYF
Celyad Oncology SA
18 Dec 23
Current report (foreign)
12:29pm
6-K
CLYYF
Celyad Oncology SA
4 Dec 23
Celyad announces management change
1:28pm
6-K
h8p4zoqb96324zulsk6n
4 Dec 23
Current report (foreign)
1:26pm
6-K
ni6ptucpq
24 Nov 23
Celyad Oncology reports third quarter 2023 financial
8:54am
6-K
g3vobu7b
21 Nov 23
Publication of a transparency notification received from
4:05pm
6-K
109grmj89tl2b
21 Nov 23
Current report (foreign)
8:06am
6-K
fbaunep1
15 Nov 23
Information on the Total Number of Voting Rights and Total Number of shares with single voting rights
4:37pm
6-K
eofee19m goi
27 Oct 23
Current report (foreign)
1:45pm
6-K
93sf ssrph5qsn5m92u
26 Sep 23
Celyad Oncology Announces the Termination of Its American Depository
6:06am
6-K
1xh9pm9 77isr
22 Sep 23
Current report (foreign)
6:06am
6-K
jxeh4dazv00 d1vy7mk8
18 Sep 23
Publication of a rectified transparency notification received from
6:04am
6-K
o22kc9cacd
13 Sep 23
Current report (foreign)
6:29am
6-K
9adyxyxw0u7hps j04
11 Sep 23
Publication of a transparency notification received
6:21am
6-K
2ntw lidax
6 Sep 23
Current report (foreign)
6:04am
SC 13D/A
w6m2fo79p4o5h
5 Sep 23
Celyad Oncology / Fortress Investment ownership change
4:32pm
6-K
f7dfu8
5 Sep 23
Celyad Oncology Reports First Half 2023 Financial
6:12am
6-K
ccosif
25 Aug 23
Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders
6:07am